T HE CYCLIC development and function of human endometrial tissues is influenced to a large extent by the secretion of estrogens and progesterone from the ovaries during the menstrual cycle (1). The secretion of P-estradiol (E,) from the ovaries during the follicular phase of the menstrual cycle stimulates the growth of the endometrium.
Progesterone secreted in the luteal phase of the cycle is in part responsible for preparation of the endometrium for implantation of the fertilized ovum. Although relatively large quantities of estrogens are also secreted from the ovaries during the luteal phase of the cycle, the endometrium is not greatly responsive to their presence (2). Several factors are involved in decreasing the responsiveness of the endometrium to estrogens, including increased estrogen metabolism and a decrease in estrogen receptor (ER) levels. Progesterone secreted from the ovaries increases both 17/3-hydroxysteroid dehydrogenase and estrogen sulfotransferase (EST) activity in endometrial tissues as well as causing the down regulation of ER levels. Hata et nl. (3) have reported that, at low nanomolar concentrations of Ez, sulfation is more important in the metabolism of E, than 17P-hydroxysteroid dehydrogenase activity. Therefore, the increases in estrogen sulfation activity in endometrial tissues in response to progesterone stimula-* This research was supported in part by NIH Grant GM-38953 (to C.N.F.). tion may have an important role in decreasing the activity of estrogens.
The metabolism of steroids in hormone responsive tissues is an important mechanism in the modulation of steroid activity. One of the mechanisms for the inactivation of steroids is via sulfate conjugation.
The addition of a sulfate moiety to a steroid decreases the binding of the steroid to its receptor, effectively lowering the concentration of the bioactive steroid. Sulfation also increases the aqueous solubility of the steroid, thereby facilitating its excretion. The conjugation of steroids with sulfate is catalyzed by a family of enzymes termed the sulfotransferases (STs). Four forms of cytosolic ST have been identified in human tissues by purification and cloning studies (4-8), and three of these enzymes have been reported to conjugate estrogens and hydroxysteroids (g-10). Dehydroepiandrosterone ST (hDHEA-ST) conjugates the 3-hydroxy position of both hydroxysteroids such as DHEA and pregnenolone, as well as many bile acids (10, 11). hDHEA-ST also conjugates estrogens and testosterone; however, the enzyme does not conjugate cortisol or dexamethasone (10). The phenol-sulfating form of phenol ST (hP-PST) conjugates only the 3-phenolic hydroxyl of estrogens and does not sulfate the aliphatic hydroxyl groups of hydroxysteroids such as DHEA, androsterone, testosterone, and cortisol (10, 12) . Recently, the cDNA for human liver estrogen ST (hEST) has been cloned (4, S), and the active enzyme has been expressed in bacteria and purified to homogeneity (8). hEST differs from hDHEA-ST and hP-PST in that hEST sulfates E, and estrone (E,) creased E, sulfation activity whereas incubation of the cells with 10 nM or 10 PM testosterone, E,, cortisol, or dexamethasone had no effect on E, sulfation activity. To investigate the possibility that progesterone metabolism may be responsible for the relatively high levels of progesterone required for hEST induction, medroxyprogesterone, which is metabolized much more slowly, was tested for its ability to induce hEST activity. Figure 3 shows that medroxyprogesterone induced hEST activity approximately 6-fold with maximal induction occurring between 10 nM and 10 FM. To further investigate the specificity of the induction of E, sulfation activity, the effect of the antiprogestin, RU-486, on the induction of E, sulfation activity was tested. Figure 4 shows that coincubation of RU-486 and progesterone with the Ishikawa cells resulted in a dose-dependent decrease in the induction of E, sulfation activity. RU-486 had no effect on the basal E, sulfation activity in these cells but prevented the stimulation of E, sulfation caused by progesterone.
Four human cytosolic STs have been identified in human tissues, and three of these enzymes have been reported to sulfate estrogens. The changes in the sulfation of specific substrates for the different forms of human ST were assayed in cytosol from progesterone-treated and control Ishikawa cells to determine which of the ST activities were being affected by the progesterone treatment. Table 1 shows that progesterone treatment significantly increased the levels of E, sulfation at 20 nM. E, sulfation assayed at 20 nM is highly specific for hEST activity (8). The sulfation of either p-nitrophenol or dopamine was not affected. At low concentrations, dopamine is a selective substrate for hM-PST and p-nitro- and does not significantly alter the activity of the two forms of PST also present in these cells. Immunoblot analysis of progesterone-treated and control Ishikawa cell cytosols using an affinity-purified rabbit anti-hEST polyclonal antibody shows an increase in hEST protein in the progesteronetreated cells as compared with control cells (Fig. 5) . Immunoblot blot analysis of these cells with specific rabbit antihPST antibodies did not detect significant differences in the expression of either hP-PST or hM-PST (data not shown).
Northern blot analysis of RNA isolated from progesteronetreated and control Ishikawa cells was performed. 28S-
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.,' t,\ ', ), ': .: i .' FIG. 6 . Northern blot analysis of RNA from control and progesteronetreated Ishikawa cells. Total RNA was isolated from quiesced Ishikawa cells 5 and 16 h after treatment with 10 KM progesterone or ethanol. Poly(A) RNA was isolated from total RNA obtained from the different treated cells using a Poly AT-tract kit. Poly(A) RNA (10 pg) was resolved by electrophoresis in a formaldehyde-urea agarose gel and transferred to a nitrocellulose membrane. Upperpanel, the membrane was probed with [32P1-labeled hEST cDNA (1 x lo9 cpm/pg) and washed as described previously (10). The presence of bound probe was visualized by phosphorescence imaging. Lanes A and C contain poly(A) RNA from control cells isolated at 5 and 16 h after treatment, respectively. Lanes B and D contain RNA from progesterone-treated cells isolated at 5 and 16 h after treatment, respectively. Lowerpanel, To determine the loading and transfer efficiency, the membrane was stripped by boiling in water and until no radioactivity was detectable on the membrane. The membrane was then probed with [32P]-labeled p-a&in (0.5 X 10' cpmpg), washed, and exposed to autoradiography film.
whether the increase in cytosolic hEST activity was reflected in an increase in the sulfation of E, added to the medium of intact cells. Figure 7 shows that the progesterone-treated cells secreted E,-sulfate into the medium approximately 4-fold more rapidly than did control cells. hEST activity in parallel cultures of Ishikawa cells treated with progesterone was also approximately 4-fold.
Discussion
Estrogen and progesterone regulation of endometrial function is an important aspect of the menstrual cycle. Studies using human endometrial tissue slices or fragments have indicated that there is an increase in estrogen sulfation in secretory endometrium as compared to proliferative endometrium in response to progesterone treatment (23,241. This report demonstrates the specific induction of human EST by progesterone in human Ishikawa endometrial adenocarcinoma cells as a model system for the increases in estrogen sulfation in human endometrium. Progesterone increased both hEST activity and immunoreactive protein but did not affect the activity of other forms of cytosolic ST. Although previous studies of estrogen sulfation indicated the presence of a high affinity EST activity in endometrial tissues and endometrial tumor cell lines, only recently has a human EST been cloned, expressed, purified, and kinetically characterized (4, 8) . Expressed hEST has a K, for both E, and E, of approximately 5 nM (8). This value is similar to the K, for E, sulfation reported by Tseng and Liu (24) using endometrial slices and by Gross0 and Way (25) for an EST activity in RL 95-2 endometrial carcinoma cells.
The affinity of hEST for E, and E, is such that the enzyme functions efficiently in the range of estrogen concentrations normally found in human endometrial tissues. The rapid intracellular sulfation of E, and E, in secretory endometrium elicited by progesterone would enhance the decrease in estrogen responsiveness associated with a decrease in ER levels Ishikawa cells also possess significant levels of both hP-PST and hM-PST activity but no detectable hDHEA-ST activity. Although hP-PST is capable of conjugating both E2 and E,, the affinity of hP-PST for estrogens is at least 400-fold lower than that of hEST. Maximal sulfation of E, and Ez by hP-PST occurs at concentrations of 6 FM and 20 FM, respectively (10). It has been reported that partially purified human liver M-PST activity does not sulfate estrogens (9). Also, cloned hM-PST expressed in bacteria was not capable of sulfating any of the steroids, including E, and E,, tested as substrates (26). The lack of modulation of hP-PST and hM-PST activities by progesterone and the low affinity of hP-PST for estrogen sulfation does not support a physiological role for these enzymes in regulating estrogen levels in Ishikawa cells.
The induction of hEST activity by progesterone apparently involves the binding of the progesterone receptor. Only progesterone and medroxyprogesterone acetate increased hEST activity in Ishikawa cells and the presence of RU-486 inhibited the increase stimulated by progesterone. The differences in the concentrations of progesterone and medroxyprogesterone needed to induce hEST activity may be related to an increased metabolism of progesterone as compared to the more slowly metabolized medroxyprogesterone. The inability of RU-486 to decrease hEST activity in untreated Ishikawa cells suggests that there is a level of constitutive expression of hEST in these cells that is independent of progesterone stimulation.
Whether significant levels of hEST occur in normal human proliferative endometrium in the relative absence of progesterone has not been reported. However, the availability of specific molecular and antibody probes for the individual human cytosolic STs will aid in these investigations.
The induction of hEST by progesterone in Ishikawa cells is the first demonstration of the regulation of a specific human ST by a steroid hormone.
In rodent tissues, multiple forms of ST are involved with the conjugation of steroids, and these STs display a clear sexual dimorphism that is related to their regulation by GH and steroid hormones (27-29). However, in humans, ST expression does not display gender-related differences in tissues such as liver, platelets, and intestine (30-32). The only regulation of a human cytosolic ST previously described is the induction of hD-HEA-ST in human adrenals by ACTH (33, 34) . The induction of hEST in endometrium in response to increased secretion of progesterone from the corpus luteum would be consistent with the proposed role of sulfation in limiting the action of estrogens during the secretory phase of the menstrual cycle. The induction of hEST in Ishikawa cells suggests that the regulation of hEST expression may also occur in other estrogen or progestin-responsive tissues.
